University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 9 of 23
Safety of Optimal PEEP in NSICU Patients
NCT03862027
Voices From the Black Community: Hepatitis C Research Participation
NCT04202081
Modulation of Cognitive Control Signals in Prefrontal Cortex by Rhythmic Transcranial Magnetic Stimulation
NCT03828734
Nudges and Incentives to Enhance the Opioid Treatment Workforce
NCT03834025
Precision Public Health: Enhancing Connections to Develop Just-in-Time Adaptive Intervention Strategies
NCT03836391
Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons
NCT03803605
Inhaled Oxytocin and HPA Axis Reactivity
NCT03593473
Genetic-specific Effects of Fructose on Liver Lipogenesis
NCT03783195
Reducing Binge Eating to Prevent Weight Gain in Black Women
NCT03531112
Uniting Couples in the Treatment of Binge-Eating Disorder
NCT03784820
Mental Health Services for Prisoners With SMI
NCT03713398
Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
NCT03740009
LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE
NCT04141046
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life
NCT03757988
Effect of Knee Bracing on Improving Pain & Disability
NCT04044612
Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study
NCT03772145
ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development)
NCT03651622
Novel MRI Sequence- MR Fingerprinting
NCT03722459
Tantrum Tamers 2.0: The Role of Emotion
NCT03597789
Choline Nutritional Status: Development of a Biomarker Panel
NCT03726671
In-vivo Effects of E-cigarette Aerosol on Innate Lung Host Defense
NCT03700892
IFI16 is a Periodontitis Modulating Protein
NCT03513497
Effects of 20,000 EU of Clinical Center Reference Endotoxin (CCRE) Versus Placebo(ENDOHEART)
NCT03623022
Effect of Cross Frequency tACS on Cognitive Control
NCT03800030
Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
NCT03556683
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
NCT03548779
Single Session of tACS in a Depressive Episode
NCT03449979
ADPKD Alterations in Hepatic Transporter Function
NCT03717883
Priming Through Timing. Using Opposing Strategies to Enhance Motor Learning for Individuals With Parkinson's Disease
NCT03660605
Improving African American Glaucoma Patient Involvement in Visits and Outcomes
NCT03657147
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
NCT03613714
Mechanisms of Manual Therapies in CAI Patients
NCT03418051
Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)
NCT03481309
Vitamin C Supplementation Intervention
NCT04036110
Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years
NCT03562481
Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury
NCT03313076
LC Bead LUMI for Prostatic Artery Embolization
NCT03372096
A Study of the Feasibility of Prehospital Remote Ischemic Conditioning
NCT03400579
Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema
NCT03619161
Study of an International Commercial Program on Weight Loss and Health Outcomes
NCT03571893
A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults
NCT03444298
Comparison of 129Xe MRI With 19F MRI in CF Lung Disease
NCT03482960
Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA)
NCT03362957
Outcomes in Children With Pre-operative Residual Hearing
NCT03379870
Patient and Family Partners in Heart Failure Care: Pilot Test of a Pre-visit Question Prompt List to Enhance Engagement During Medical Visits
NCT03491800
Impact of Sugar-Sweetened Beverage Health Warnings
NCT03511937
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062
4-week Mindfulness Program for Adults With Chronic Pain
NCT03495856
Conventional Bite Wing Radiography Versus Stationary Intraoral Tomosynthesis, a Comparison Study
NCT02873585
University of North Carolina-Healthwise Partnership Project on Birth Options Decision Aid
NCT04053413
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.